IMCI Pharmaceuticals

IMCI Pharmaceuticals is a dynamic pharmaceutical company dedicated to developing innovative, pharma-grade, and precisely formulated cannabis-based medications. Focused on treating chronic indications, IMCI Pharmaceuticals is committed to providing effective solutions with a global reach, enhancing patient well-being through advanced pharmaceutical research and development.

IMCI Pharmaceuticals has pioneered the iCann medicinal cannabis platform, ensuring a precise and effective dose with easy administration suitable for diverse patient populations, anytime and anywhere. With a strong foundation in research and development, IMCI Pharmaceuticals leverages collaboration with leading academic research institutions and established pharmaceutical providers to create cutting-edge cannabis-based medications.

Operating from its primary location in Amsterdam, NL, with additional sites in Ashdod, IL, and Johannesburg, ZA, IMCI Pharmaceuticals continues to expand its reach and impact in the pharmaceutical sector. IMCI Pharmaceuticals is poised for continued growth and innovation in the pharmaceutical industry. We invite the management of IMCI Pharmaceuticals to create a customized and exclusive company showcase and product listing on our platform to further highlight your innovative solutions.